Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Receptos

  • People in the News
    ... Graham Cooper is now CFO at Receptos...Aratana Therapeutics added Don Stitzenberg as vp of manufacturing and Tammy Newbold as vp of chemistry, manufacturing, and controls. JonEric ...
    3-15-2013
  • Receptos Licenses AbbVie Antibody for Co-Development
    Receptos agreed to license a humanized anti-interleukin-13 (IL-13) antibody from AbbVie, ... Financial terms were not disclosed. Receptos, a San Diego developer of drugs for immune ...
    3-13-2013
  • A Good Day for Milestones
    versions of blood factor proteins, and Receptos achieved a milestone with Ono ... The current milestone, achieved by Receptos determining a novel GPCR structure for Ono, ...
    3-7-2013
  • Top 20 Venture Capital Firms
    Permeon Biologics, PhaseRx, Pulmatrix, Receptos, Sorbent therapeutics, Theraclone ... Pharmaceuticals, Promedior, Pulmatrix, Receptos, Xtuit Pharmaceuticals Typical ...
    12-17-2012
  • People in the News
    ... Hasnain is currently president and CEO of Receptos. He has also held executive and leadership roles at Facet Biotech, PDL BioPharma, Biogen Idec, Bristol Myers-Squibb, and ...
    10-1-2012
  • Ono, Receptos Ink GPCR Drug Discovery Collaboration
    Ono Pharmaceutical and Receptos inked an R&D collaboration focused on the development of small molecule modulators against an undisclosed GPCR target. Receptos will use its GPCR ...
    12-13-2011
  • Receptos and Lilly Enter Agreement Focused on a GPCR Target
    Receptos and Eli Lilly agreed to research and develop orally delivered small molecule ... partners or on an independent basis," says Faheem Hasnain, president and CEO of Receptos. ...
    1-6-2011
  • Structural Biology Underpins R&D Efforts
    Receptos is using structural biology to get an accurate picture of the binding pocket of ... Receptos uses standard structural biology tools to work on G-protein-coupled receptors ...
    10-1-2010
  • Receptos Raises $25M in Series A Financing
    GPCR drug discovery company Receptos completed a two-tranche, $25 million Series A round ... To help with the prioritization of its clinical drug candidates, Receptos has determined ...
    11-23-2009

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll